Our structure
Executive Board
Florence Baron-Papillon
President (Sanofi)
Juan Carlos Jaramillo
Vice-President & Treasurer (Valneva)
Andreas Potthoff
(Abbott)
Lorenzo Wittum
(AstraZeneca)
Basil Babychan
(Bilthoven Biologicals)
John-Kenneth Billingsley
(CSL Seqirus)
Tanja Veikkola
(GSK)
Jörg Jenewein
(Moderna)
Nicoletta Luppi
(MSD)
Tobias Cousens
(Pfizer)
Walid Kandeil
(Takeda)
Executive Office
Sibila Quilici
Executive Director
Laurent Louette
Director Public Affairs & Country Liaison
Anna Czwarno
Director, Regulatory, Manufacturing & Supply
Charlotte Vernhes
Director, Scientific and Medical Affairs
Anna Vicere
Director, Public Affairs & Access Policy
Ingrid Weindorfer
Project Manager
Kateryna Khmilevska
Junior Science and Regulatory Manager
Alina Juuti
Associate Director, Communications & Policy
Polina Zoteva
Communications Lead
Eva Antunano
Assistant Manager
Working Group Chairs
Public Affairs
Mark Canavan
Sanofi
Regulatory Affairs
Andrew Deavin
GSK
RESEARCH, INNOVATION & MEDICAL
Lucie Rochard
Sanofi
Market Access
Kathleen Grieve
MSD
Manufacturing & Supply
Niko Salo
Pfizer
NATIONAL VACCINE INDUSTRY GROUP’S TASK FORCE
Gisela Payeras Bailly
GSK